This announcement is a separate document:
华润双鹤关于全资子公司双鹤药业(海南)有限责任公司注射用奥美拉唑钠通过仿制药质量和疗效一致性评价的公告
Announcement of China Resources Shuanghe on the consistent evaluation of the quality and efficacy of generic drugs for injection of omeprazole sodium by its wholly-owned subsidiary Shuanghe Pharmaceutical (Hainan) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated